Switch theme
Sign up to access all valuation multiples
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. It also offers services such as training in connection with product sales. Geographically, it derives a majority of revenue from Western Europe and also has a presence in North America; and the Rest of the World.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Arjo has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Arjo achieved revenue of $1.2B and an EBITDA of $207M.
Arjo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Arjo valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | XXX | XXX | XXX |
| Gross Profit | $434M | $488M | XXX | XXX | XXX |
| Gross Margin | 38% | 42% | XXX | XXX | XXX |
| EBITDA | $202M | $207M | XXX | XXX | XXX |
| EBITDA Margin | 18% | 18% | XXX | XXX | XXX |
| Net Profit | $46.1M | $49.5M | XXX | XXX | XXX |
| Net Margin | 4% | 4% | XXX | XXX | XXX |
| Net Debt | $432M | $351M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, Arjo's stock price is SEK 31 (or $3).
Arjo has current market cap of SEK 8.6B (or $884M), and EV of SEK 9.2B (or $945M).
See Arjo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $945M | $884M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, Arjo has market cap of $884M and EV of $945M.
Arjo's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Arjo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Arjo and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $945M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 4.6x | XXX | XXX | XXX |
| P/E | 17.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 10.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialArjo's NTM/LTM revenue growth is n/a
Arjo's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged n/a for the same period.
Over next 12 months, Arjo's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Arjo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Arjo and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Arjo acquired XXX companies to date.
Last acquisition by Arjo was XXXXXXXX, XXXXX XXXXX XXXXXX . Arjo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Arjo founded? | Arjo was founded in 1957. |
| Where is Arjo headquartered? | Arjo is headquartered in Sweden. |
| How many employees does Arjo have? | As of today, Arjo has 6.7K+ employees. |
| Who is the CEO of Arjo? | Arjo's CEO is Mr. Joacim Lindoff. |
| Is Arjo publicy listed? | Yes, Arjo is a public company listed on STO. |
| What is the stock symbol of Arjo? | Arjo trades under ARJO B ticker. |
| When did Arjo go public? | Arjo went public in 2017. |
| Who are competitors of Arjo? | Similar companies to Arjo include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Arjo? | Arjo's current market cap is $884M |
| What is the current revenue growth of Arjo? | Arjo revenue growth between 2023 and 2024 was 3%. |
| Is Arjo profitable? | Yes, Arjo is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
